Cargando…

Daily hemodialysis practices in Australia/New Zealand and in France: a comparative cohort study

BACKGROUND: As patients on daily hemodialysis (DHD) have heterogeneous profiles, DHD benefit in terms of survival is still debated. The aim of this study was to compare DHD practices in France and in Australia and New Zealand. METHODS: This study was based on data from the French Renal Epidemiology...

Descripción completa

Detalles Bibliográficos
Autores principales: Pladys, Adélaïde, Bayat, Sahar, Couchoud, Cécile, Vigneau, Cécile, McDonald, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505110/
https://www.ncbi.nlm.nih.gov/pubmed/31064344
http://dx.doi.org/10.1186/s12882-019-1330-1
_version_ 1783416691646005248
author Pladys, Adélaïde
Bayat, Sahar
Couchoud, Cécile
Vigneau, Cécile
McDonald, Stephen
author_facet Pladys, Adélaïde
Bayat, Sahar
Couchoud, Cécile
Vigneau, Cécile
McDonald, Stephen
author_sort Pladys, Adélaïde
collection PubMed
description BACKGROUND: As patients on daily hemodialysis (DHD) have heterogeneous profiles, DHD benefit in terms of survival is still debated. The aim of this study was to compare DHD practices in France and in Australia and New Zealand. METHODS: This study was based on data from the French Renal Epidemiology and Information Network (REIN) and the Australian and New Zealand Dialysis and Transplant Registry (ANZDATA). All incident patients from both registries who underwent DHD (i.e., 5–6 sessions/week, including short daily hemodialysis and long nocturnal hemodialysis) at least once during their trajectories were included, and their characteristics and care trajectories were compared. For survival analyses, one French patient was matched to one Australian or New Zealand patient, based on age, sex and year of dialysis start. Survival was assessed using the Cox proportional hazards model, and access to renal transplantation was evaluated using the Fine & Gray model to take into account death as competing risk. RESULTS: Between 2003 and 2012, 523 patients from the AZNDATA and 753 from the REIN registry started DHD. ANZDATA patients were younger (54.8 vs 64.0 years, p < 0.001) and had comorbidities more frequently than French patients. In both registries, one third of patients were on early DHD (i.e., DHD started less than one year after dialysis initiation). Long nocturnal hemodialysis was more frequent in the ANZDATA than in the REIN cohort (20.8 and 3%, respectively). Comparison of the matched subgroups showed comparable survival rates between French and Australian/New Zealand patients (HRadjusted = 1.08; 95%CI: 0.78–1.50). Access to renal transplantation also was similar between matched groups (SHRadjusted = 1.30, 95%CI: 0.86–1.97). CONCLUSIONS: Our study shows that, despite differences in terms of patients’ characteristics and DHD regimens, the mortality risk and access to renal transplantation are similar in France and Australia and New Zealand. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-019-1330-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6505110
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65051102019-05-10 Daily hemodialysis practices in Australia/New Zealand and in France: a comparative cohort study Pladys, Adélaïde Bayat, Sahar Couchoud, Cécile Vigneau, Cécile McDonald, Stephen BMC Nephrol Research Article BACKGROUND: As patients on daily hemodialysis (DHD) have heterogeneous profiles, DHD benefit in terms of survival is still debated. The aim of this study was to compare DHD practices in France and in Australia and New Zealand. METHODS: This study was based on data from the French Renal Epidemiology and Information Network (REIN) and the Australian and New Zealand Dialysis and Transplant Registry (ANZDATA). All incident patients from both registries who underwent DHD (i.e., 5–6 sessions/week, including short daily hemodialysis and long nocturnal hemodialysis) at least once during their trajectories were included, and their characteristics and care trajectories were compared. For survival analyses, one French patient was matched to one Australian or New Zealand patient, based on age, sex and year of dialysis start. Survival was assessed using the Cox proportional hazards model, and access to renal transplantation was evaluated using the Fine & Gray model to take into account death as competing risk. RESULTS: Between 2003 and 2012, 523 patients from the AZNDATA and 753 from the REIN registry started DHD. ANZDATA patients were younger (54.8 vs 64.0 years, p < 0.001) and had comorbidities more frequently than French patients. In both registries, one third of patients were on early DHD (i.e., DHD started less than one year after dialysis initiation). Long nocturnal hemodialysis was more frequent in the ANZDATA than in the REIN cohort (20.8 and 3%, respectively). Comparison of the matched subgroups showed comparable survival rates between French and Australian/New Zealand patients (HRadjusted = 1.08; 95%CI: 0.78–1.50). Access to renal transplantation also was similar between matched groups (SHRadjusted = 1.30, 95%CI: 0.86–1.97). CONCLUSIONS: Our study shows that, despite differences in terms of patients’ characteristics and DHD regimens, the mortality risk and access to renal transplantation are similar in France and Australia and New Zealand. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-019-1330-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-05-07 /pmc/articles/PMC6505110/ /pubmed/31064344 http://dx.doi.org/10.1186/s12882-019-1330-1 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Pladys, Adélaïde
Bayat, Sahar
Couchoud, Cécile
Vigneau, Cécile
McDonald, Stephen
Daily hemodialysis practices in Australia/New Zealand and in France: a comparative cohort study
title Daily hemodialysis practices in Australia/New Zealand and in France: a comparative cohort study
title_full Daily hemodialysis practices in Australia/New Zealand and in France: a comparative cohort study
title_fullStr Daily hemodialysis practices in Australia/New Zealand and in France: a comparative cohort study
title_full_unstemmed Daily hemodialysis practices in Australia/New Zealand and in France: a comparative cohort study
title_short Daily hemodialysis practices in Australia/New Zealand and in France: a comparative cohort study
title_sort daily hemodialysis practices in australia/new zealand and in france: a comparative cohort study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505110/
https://www.ncbi.nlm.nih.gov/pubmed/31064344
http://dx.doi.org/10.1186/s12882-019-1330-1
work_keys_str_mv AT pladysadelaide dailyhemodialysispracticesinaustralianewzealandandinfranceacomparativecohortstudy
AT bayatsahar dailyhemodialysispracticesinaustralianewzealandandinfranceacomparativecohortstudy
AT couchoudcecile dailyhemodialysispracticesinaustralianewzealandandinfranceacomparativecohortstudy
AT vigneaucecile dailyhemodialysispracticesinaustralianewzealandandinfranceacomparativecohortstudy
AT mcdonaldstephen dailyhemodialysispracticesinaustralianewzealandandinfranceacomparativecohortstudy